• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Infliximab Product Information - Licensing Action

Proper name: Infliximab
Tradename: Remicade
Manufacturer: Centocor Inc, Malvern, PA, License #1242
Expanded Indication for Use: Inhibition of progression of structural damage in patients with rheumatoid arthritis who have had an inadequate response to methotrexate
Approval Date: 12/29/2000
Type of submission: Biologics license supplement


Approval Letter (PDF) 

Label (PDF)